Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Home Newsfeeds Cleveland Research Downgrades Roku to Neutral

Cleveland Research Downgrades Roku to Neutral

Cleveland Research downgrades Roku (NASDAQ:ROKU) from Buy to Neutral.

byBenzinga Newsdesk

October 26, 2022

1 minute read

Cleveland Research downgrades Roku (NASDAQ:ROKU) from Buy to Neutral.

Loop Capital Initiates Coverage On Applied Materials with Buy Rating, Announces Price Target of $125

By Benzinga Newsdesk

December 7, 5:40 AM

Loop Capital analyst Scott Graham initiates coverage on Applied Materials (NASDAQ:AMAT) with a Buy rating and announces Price Target of $125.

AMAT

The Science Times Publishes Article About Jaguar Health’s Focus On Developing Crofelemer For Two Rare Disease Indications

By Happy Mohamed

August 30, 8:37 AM

Jaguar is supporting investigator-initiated proof-of-concept studies of crofelemer for the rare disease indications of short bowel syndrome and microvillus inclusion disease in the EU and Middle East/North Africa

JAGX

Analyst Ratings

Expert Ratings for Carlyle Group

By Benzinga Insights

May 5, 12:01 PM

Analysts have provided the following ratings for Carlyle Group (NASDAQ:CG) within the last quarter: Bullish Somewhat Bullish Indifferent…

Target Stock Soars On Q2 Earnings: Higher Margins, Lower Inventory And More

By Shivani Kumaresan

August 16, 7:28 AM

Target Corp (NYSE: TGT) reported a second-quarter FY23 sales decline of 4.9% year-on-year to $24.77 billion,

TGT

Cleveland Research Downgrades Roku to Neutral

Related Posts

Loop Capital Initiates Coverage On Applied Materials with Buy Rating, Announces Price Target of $125

The Science Times Publishes Article About Jaguar Health’s Focus On Developing Crofelemer For Two Rare Disease Indications

Expert Ratings for Carlyle Group

Target Stock Soars On Q2 Earnings: Higher Margins, Lower Inventory And More